Investors Contact Payment Careers Research Request
Interpace Biosciences®, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
  • Support
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics Issues Update Regarding Announced Contract with BCBS of Massachusetts

Mar 11, 2020

Interpace Diagnostics Announces Contract with BCBS of Massachusetts

Mar 10, 2020

Interpace Biosciences Announces Acceptance of first paper Demonstrating Clinical Performance of ThyGeNEXT with ThyraMIR

Mar 2, 2020

Interpace Announces Extension of LabCorp Agreement

Feb 24, 2020

Interpace Biosciences Announces Another Pricing improvement for its Thyroid Assay

Feb 11, 2020

Interpace Biosciences Announces Addition to Board of Directors and Changes in Leadership

Jan 30, 2020

Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners

Jan 13, 2020

Interpace Biosciences Announces Collaborative Study with University of North Carolina to Assess the Use BarreGEN® after Ablation of Dysplastic Barrett’s Esophagus

Jan 6, 2020

Interpace Biosciences Announces New Draft LCD and Reimbursement for Its Proprietary Thyroid Assay, ThyGeNEXT®

Dec 17, 2019

Interpace Biosciences Expands Strategic Partnership Activities with Genecast Biotechnology in China

Dec 5, 2019
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...22
    © 2023 Interpace Biosciences®, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    We Own Our Future Logo
    • Linkedin